OR52N4 Antibody

What is OR52N4 and why are antibodies against it important for research?

OR52N4 (Olfactory Receptor Family 52 Subfamily N Member 4) is an olfactory receptor protein encoded by the OR52N4 gene in humans (Gene ID: 390072). It functions as an odorant receptor and is a multi-pass membrane protein primarily localized to the cell membrane . Antibodies against OR52N4 are important research tools for studying olfactory signaling pathways, sensory perception mechanisms, and potentially certain neurological disorders related to olfactory dysfunction. The investigation of olfactory receptors contributes to our understanding of how environmental chemical signals are transduced into neurological responses .

What applications are OR52N4 antibodies validated for?

Based on current validation data, OR52N4 antibodies are primarily validated for the following applications:

Researchers should note that optimal dilutions may vary between different antibody products and experimental conditions. It is recommended to perform optimization experiments when using the antibody for the first time in a particular application or experimental system .

What species reactivity can be expected from commercially available OR52N4 antibodies?

The species reactivity of commercially available OR52N4 antibodies varies by manufacturer. Based on the available data:

When planning cross-species experiments, researchers should verify the antibody's specificity for the target organism through pilot experiments, as cross-reactivity may not always indicate equivalent performance across species .

How should I design Western blot experiments to detect OR52N4 protein?

When designing Western blot experiments to detect OR52N4, several methodological considerations are important:

Sample Preparation:

• OR52N4 is a membrane protein with a calculated molecular weight of approximately 36 kDa, though it may be observed at approximately 72 kDa on Western blots due to post-translational modifications or dimerization .

• Use appropriate lysis buffers containing detergents suitable for membrane protein extraction.

• Include protease inhibitors to prevent degradation during sample preparation.

Protocol Optimization:

• Use the recommended antibody dilution range (1:500-1:2000) as a starting point, but optimize for your specific experimental conditions.

• Include both positive controls (such as HeLa cell lysates, which have been validated for OR52N4 detection) and negative controls (where the antibody is blocked by the immunizing peptide).

• For membrane proteins, transfer conditions may need optimization to ensure efficient protein transfer from gel to membrane.

Detection:

• Secondary antibody selection should be compatible with the primary antibody host (rabbit IgG for the antibodies in the search results) .

• For enhanced sensitivity, consider using HRP-conjugated secondary antibodies with chemiluminescence detection systems.

Validation data from the manufacturers indicates successful detection of OR52N4 in human cell lines, particularly HeLa cells .

What are the optimal conditions for immunofluorescence experiments using OR52N4 antibodies?

For optimal immunofluorescence results with OR52N4 antibodies, consider the following methodological approach:

Fixation and Permeabilization:

• Since OR52N4 is a membrane protein, use fixation methods that preserve membrane structure (e.g., 4% paraformaldehyde).

• For permeabilization, use mild detergents (0.1-0.2% Triton X-100 or 0.1% saponin) to allow antibody access while preserving membrane protein epitopes.

Antibody Incubation:

• Use the recommended dilution range (1:200-1:1000) as a starting point.

• Incubate at 4°C overnight for optimal binding and reduced background.

• Include blocking steps with 5-10% normal serum from the same species as the secondary antibody.

Detection and Imaging:

• Select secondary antibodies with bright, photostable fluorophores (e.g., Alexa Fluor dyes).

• Include DAPI or another nuclear counterstain for cellular orientation.

• Capture images using confocal microscopy for better resolution of membrane localization.

Controls:

• Include a negative control without primary antibody to assess secondary antibody background.

• When possible, include a competitive peptide blocking control using the immunizing peptide (amino acids 272-321 of human OR52N4) .

The expected pattern is primarily membrane localization, consistent with OR52N4's function as a multi-pass membrane protein .

How can I validate the specificity of OR52N4 antibodies in my experimental system?

Validating antibody specificity is crucial for reliable research outcomes. For OR52N4 antibodies, consider these methodological approaches:

Peptide Competition Assay:

• Preincubate the antibody with excess immunizing peptide (derived from amino acids 272-321 of human OR52N4) .

• Run parallel experiments with blocked and unblocked antibody.

• Disappearance of signal in the peptide-blocked sample confirms specificity for the target epitope.

Genetic Approaches:

• Use cells with OR52N4 knockdown/knockout as negative controls.

• Overexpression systems can serve as positive controls with increased signal intensity.

• CRISPR-Cas9 edited cell lines can provide definitive validation.

Multiple Antibody Validation:

• Use antibodies from different manufacturers or those recognizing different epitopes of OR52N4.

• Concordant results with multiple antibodies increase confidence in specificity.

Cross-reactivity Assessment:

• Test the antibody on samples from multiple species if cross-reactivity is claimed (human, mouse, rat) .

• Compare observed molecular weights with predicted values for each species.

Immunoprecipitation Followed by Mass Spectrometry:

• For ultimate confirmation, immunoprecipitate with the OR52N4 antibody and identify pulled-down proteins by mass spectrometry.

Document these validation steps thoroughly in your research methods to strengthen the credibility of your findings.

What are common technical challenges when working with OR52N4 antibodies and how can they be addressed?

Researchers working with OR52N4 antibodies may encounter several technical challenges:

High Background in Immunostaining:

• Problem: Nonspecific binding leading to high background signal.

• Solution: Increase blocking time (2-3 hours at room temperature), use higher concentrations of blocking agents (5-10% serum), and optimize antibody dilution. Additional washes with 0.1% Tween-20 can help reduce background .

Multiple Bands in Western Blot:

• Problem: Detection of bands at unexpected molecular weights.

• Solution: OR52N4 has a calculated molecular weight of 36 kDa but may appear around 72 kDa due to post-translational modifications or dimerization . Use positive controls and peptide blocking to identify specific bands. Optimize sample preparation to minimize protein degradation by including protease inhibitors .

Weak Signal Intensity:

• Problem: Insufficient signal strength for reliable detection.

• Solution: Increase protein loading for Western blots, extend primary antibody incubation time (overnight at 4°C), reduce antibody dilution, or use signal enhancement systems. For IF/ICC, consider antigen retrieval methods if applicable .

Poor Reproducibility:

• Problem: Inconsistent results between experiments.

• Solution: Standardize protocols, use consistent cell/tissue types and preparation methods, and maintain consistent antibody aliquots to avoid freeze-thaw cycles. Store antibodies according to manufacturer recommendations (-20°C for long-term, 4°C for up to one month for frequent use) .

Cross-reactivity Issues:

• Problem: Unexpected reactivity with non-target proteins.

• Solution: Validate antibody specificity using peptide competition assays. Consider using multiple antibodies targeting different epitopes of OR52N4 for confirmation .

How should I interpret variations in OR52N4 protein expression across different cell types and experimental conditions?

Interpreting variations in OR52N4 expression requires careful consideration of biological and technical factors:

Biological Factors:

Technical Considerations:

• Antibody Sensitivity: Different antibody clones may have varying sensitivities, affecting the apparent expression level. Use consistent antibody lots when comparing across experiments.

• Detection Method Linearity: Ensure your detection system operates within its linear range for accurate quantification. Include standard curves or dilution series when possible.

• Normalization Strategy: For quantitative comparisons, normalize OR52N4 expression to appropriate housekeeping proteins that remain stable under your experimental conditions.

Analytical Approach:

• Use multiple technical and biological replicates (minimum n=3) for statistical validity.

• Apply appropriate statistical tests based on your experimental design and data distribution.

• Consider complementary approaches (qPCR, flow cytometry) to corroborate protein expression findings.

When reporting variations in expression, clearly distinguish between technical variability and biologically meaningful changes by including appropriate controls and statistical analyses.

What are potential sources of false positive and false negative results when detecting OR52N4, and how can they be mitigated?

Understanding and mitigating potential sources of erroneous results is critical for research integrity:

Sources of False Positives:

• Cross-reactivity with Similar Proteins:

  • OR52N4 belongs to the olfactory receptor family, which contains many members with sequence homology.

  • Mitigation: Verify antibody specificity through peptide competition assays using the immunizing peptide (aa 272-321) . Include knockout/knockdown controls when possible.

• Non-specific Binding:

  • Secondary antibody binding to Fc receptors or hydrophobic interactions with membrane proteins.

  • Mitigation: Include adequate blocking steps, use Fc receptor blocking reagents when working with certain cell types, and include a secondary-antibody-only control .

• Autofluorescence or Endogenous Peroxidase Activity:

  • Natural fluorescence or enzymatic activity in samples that may be misinterpreted as positive signal.

  • Mitigation: Include unstained controls, quench endogenous peroxidase (for HRP-based detection), and use appropriate filters for autofluorescence subtraction in imaging .

Sources of False Negatives:

• Epitope Masking or Destruction:

  • Fixation or sample preparation may alter the epitope recognized by the antibody (aa 272-321).

  • Mitigation: Test multiple fixation protocols, consider antigen retrieval methods, and optimize sample preparation procedures .

• Insufficient Antibody Penetration:

  • Particularly relevant for IF/ICC of membrane proteins like OR52N4.

  • Mitigation: Optimize permeabilization conditions, extend antibody incubation times, and consider using smaller antibody fragments or nanobodies for dense tissues .

• Protein Degradation:

  • Loss of target protein during sample preparation.

  • Mitigation: Include protease inhibitors, maintain cold temperatures during processing, and minimize time between sample collection and fixation/freezing .

• Expression Below Detection Threshold:

  • Low abundance of OR52N4 in certain cell types or conditions.

  • Mitigation: Use signal amplification methods (e.g., tyramide signal amplification), more sensitive detection systems, or consider enrichment strategies before analysis .

Implementing robust controls and standardized protocols will significantly reduce the risk of both false positive and false negative results.

How can OR52N4 antibodies be used to study olfactory receptor trafficking and localization?

OR52N4 antibodies can be powerful tools for investigating olfactory receptor trafficking and subcellular localization:

Methodological Approaches:

• Live-Cell Imaging Studies:

  • Combine OR52N4 antibodies with membrane markers to track receptor movement in real-time.

  • For extracellular epitopes, non-permeabilizing protocols with fluorophore-conjugated antibodies can monitor surface expression dynamics.

  • Time-lapse microscopy following odorant stimulation can reveal internalization and recycling patterns.

• Co-localization Analysis:

  • Dual immunostaining of OR52N4 with organelle markers (endoplasmic reticulum, Golgi apparatus, endosomes) can map the intracellular trafficking pathway.

  • Confocal microscopy with z-stack acquisition enables 3D reconstruction of receptor distribution.

  • Quantitative co-localization metrics (Pearson's coefficient, Manders' overlap) can objectively measure association with cellular compartments .

• Biotinylation and Surface Protein Analysis:

  • Cell-surface biotinylation followed by pull-down and Western blot with OR52N4 antibodies can quantify plasma membrane expression.

  • Pulse-chase experiments can track receptor internalization rates following ligand binding.

• Super-Resolution Microscopy:

  • Techniques like STORM, PALM, or STED can resolve nanoscale distribution patterns of OR52N4 beyond the diffraction limit.

  • These approaches can identify receptor clustering in specialized membrane domains.

The cellular localization data from the search results confirms that OR52N4 is a multi-pass membrane protein , making these antibodies particularly valuable for studying membrane protein dynamics in the olfactory system and potentially in other tissues where this receptor may be expressed.

What experimental approaches can be used to study OR52N4 interactions with signaling partners?

Understanding OR52N4's interactions with signaling partners is crucial for elucidating its functional role in olfactory transduction:

Co-immunoprecipitation (Co-IP) Approaches:

• OR52N4 antibodies can be used to pull down the receptor complex from cell lysates.

• Associated proteins can be identified by Western blot (for known partners) or mass spectrometry (for unbiased discovery).

• Reverse Co-IP with antibodies against suspected interacting partners can confirm interactions.

• For membrane protein complexes like OR52N4, consider using crosslinking reagents or specialized detergents to preserve interactions .

Proximity Ligation Assay (PLA):

• This technique can detect protein-protein interactions in situ with high sensitivity.

• Requires antibodies against OR52N4 and potential interacting partners from different host species.

• Provides spatial information about where in the cell the interaction occurs.

• Particularly valuable for transient interactions in response to odorant stimulation.

FRET/BRET Analysis:

• When combined with fluorescent protein tagging approaches, antibodies can validate the expression and functionality of fusion constructs.

• These techniques can measure dynamic interactions in living cells following stimulation.

Functional Signaling Assays:

• Use OR52N4 antibodies to confirm receptor expression in heterologous expression systems.

• Measure downstream signaling events (cAMP, calcium flux, ERK phosphorylation) in response to potential ligands.

• Blocking antibodies (if available) can be used to inhibit specific interactions and assess functional consequences.

Protein-Ligand Interaction Studies:

• Combine OR52N4 antibodies with ligand-binding assays to correlate receptor conformational changes with binding events.

• Immunoprecipitation followed by ligand competition can identify binding sites and affinities.

According to the Reactome pathway database, OR52N4 is involved in specific signaling pathways (R-HSA-9752946) , making these interaction studies particularly relevant for understanding olfactory signal transduction.

What are emerging research areas where OR52N4 antibodies might contribute to scientific discoveries?

OR52N4 antibodies have potential applications in several emerging research areas:

Ectopic Expression and Non-canonical Functions:

• Recent research suggests olfactory receptors may have functions beyond the nasal epithelium.

• OR52N4 antibodies can help map expression in non-olfactory tissues and investigate potential roles in:

  • Chemosensation in the gut epithelium

  • Neurodevelopmental processes

  • Cancer biology (several olfactory receptors have been implicated in tumor progression)

  • Metabolic regulation

• Immunohistochemical screening across tissue arrays could reveal unexpected expression patterns .

Single-Cell Analysis Applications:

• OR52N4 antibodies compatible with flow cytometry or CyTOF can identify specific olfactory sensory neuron populations.

• Integration with single-cell transcriptomics can correlate protein expression with gene expression profiles.

• These approaches could reveal heterogeneity within olfactory neuron populations and identify new cellular subtypes.

3D Organoid and Tissue Engineering:

• OR52N4 antibodies can validate the presence and functionality of olfactory receptors in:

  • Olfactory epithelium organoids

  • Bioengineered sensory systems

  • Nasal tissue models for drug delivery studies

• Monitoring receptor expression during differentiation can inform optimized protocols for generating functional sensory cells in vitro .

Structural Biology and Drug Discovery:

• Antibodies recognizing specific epitopes (like the 272-321 amino acid region) can provide insights into receptor conformation.

• Combining structural studies with antibody epitope mapping can inform structure-function relationships.

• Conformational-specific antibodies could potentially distinguish between active and inactive receptor states.

Neurodegenerative Disease Research:

• Olfactory dysfunction is an early symptom in several neurodegenerative conditions (Alzheimer's, Parkinson's).

• OR52N4 antibodies could help investigate changes in receptor expression, trafficking, or function in disease models.

• Potential biomarker development for early disease detection based on olfactory receptor alterations.

These emerging applications highlight the versatility of OR52N4 antibodies beyond traditional olfactory research and underscore their potential contribution to interdisciplinary scientific discoveries.